Caxton Advantage Life Sciences Fund

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 5, 2010	Gemin X Pharmaceuticals	$8.0M Series E	Caxton Advantage Life Sciences Fund, Sanderling Ventures	—
Apr 20, 2010	Gemin X Pharmaceuticals	$16.0M Series D	Caxton Advantage Life Sciences Fund, Sanderling Ventures	—

Total Raised

N/A

Valuation

N/A